Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) :
Axiom Compliance has been assisting customer by providing expertise at the cutting edge of chemical exposure, hazard and risk assessment science. With this background, we are ideally positioned to help clients understand and manage the wider business risks and opportunities that arise in response to both increased obligations of suppliers and/or customers and chemical safety information resulting from REACH.
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) is the Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorization and Restriction of Chemicals. It came into force on 1 June 2007. REACH addresses the production and use of chemical substances, and their potential impacts on both human health and the environment.
The European Chemicals Agency has set three major deadlines for registration of chemicals. In general these are determined by tonnage manufactured or imported, with 1000 tonnes/a. being required to be registered by 1 December 2010, 100 tonnes/a. by 1 June 2013 and 1 tonne/a. by 1 June 2018.
Companies have the responsibility of collecting information on the properties and the uses of substances that they manufacture or import at or above one tonne per year. They also have to make an assessment of the hazards and potential risks presented by the substance..
This information is communicated to ECHA through a registration dossier containing the hazard information and, where relevant, an assessment of the risks that the use of the substance may pose and how these risks should be controlled.
ECHA and the Member States evaluate the information submitted by companies to examine the quality of the registration dossiers and the testing proposals and to clarify if a given substance constitutes a risk to human health or the environment.Once the evaluation is done, registrants may be required to submit further information on the substance.
The authorisation procedure aims to assure that the risks from Substances of Very High Concern are properly controlled and that these substances are progressively replaced by suitable alternatives while ensuring the good functioning of the EU internal market.